1. We All Scream for Ice Cream

    By Margaret Martin, RD, MS, LDN | July 2016 What is America's favorite dessert? Ice cream is definitely in the running! Did you know that ice cream can be beneficial for cancer survivors? Ice cream can help you manage side effects from cancer and cancer treatment such as weight loss, sore mouth, sore throat, and change in taste and smell. During cancer treatment, sometimes it is difficult to find a food, texture, or flavor that's appealing. The possible flavors and textures of ice cream...

    Read More
  2. Cancer Wasn’t Going to Stop Me

    When I entered Rutgers University, I thought, “This is the beginning of the rest of my life.” Little did I know that virtually my entire college career I would be battling cancer. I was sick and had mono symptoms at least twice a month my entire freshman year, developed a lump on my neck the fall semester of my sophomore year, and after a surgery to remove the lump, was diagnosed with Hodgkin lymphoma. I just turned 20 and I had cancer. I thought my life was over. I kept thinking, “...

    Read More
  3. Announcing our New Medication Resource for Myeloma Patients

    While living with myeloma, you may have a number of different medications to take at home - medications you took prior to diagnosis, those you now take to treat myeloma, and others to reduce the side effects of treatment. The effectiveness of your medication is best when you follow your medication course as prescribed by your doctor or pharmacist. LLS is happy to share a new calendar to help you with your oral medication routine. The calendar includes helpful tips, a section for you to...

    Read More
  4. Cancer Researcher Runs Alaska Half Marathon to Raise Funds for Lifesaving Treatments

    Not only has Irene Ghobrial, M.D. dedicated her professional life to finding lifesaving treatments for cancer, but over the past few months she has dedicated her leisure time to training for a half marathon in Alaska, to raise funds for cancer research. Ghobrial has trained with The Leukemia & Lymphoma Society’s (LLS) Team In Training (TNT), the non-profit’s endurance training program. Ghobrial, a Dana-Farber Cancer Institute (DFCI) physician-scientist, has been closely affiliated ...

    Read More
  5. A Vaccine to Treat Mantle Cell Lymphoma?

    Ronald Levy, professor of medicine and former chief of the Division of Oncology at Stanford University School of Medicine, helped develop and test the first US Food and Drug Administration (FDA)-approved monoclonal antibody against cancer for the treatment of B-cell lymphoma. Rituximab is now a standard of treatment alone and also in combination with chemotherapy regimens. Levy is receiving LLS funding through the Translational Research Program for research into an immunotransplant...

    Read More
  6. Should I Take Dietary Supplements?

    When diagnosed with cancer, you are eager to do whatever it takes to beat your disease. Part of that eagerness may be to use dietary supplements, such as vitamins; minerals; or herbal, botanical, enzyme or amino acid products and liquids. Not all supplements are safe or effective for all cancer survivors. Yet, some cancer centers report that 25 to 77 percent of patients take dietary supplements outside of their treatment plan developed by their healthcare team. Is this the right thing to do? ...

    Read More
  7. VP Biden Addresses Researchers @ ASCO16

    Speaking from the heart, Vice President Joseph Biden addressed thousands of cancer researchers today in a packed hall at the American Society of Clinical Oncology (#ASCO16) annual meeting in Chicago, to tout his Cancer Moonshot initiative. The theme of this year’s #ASCO16 meeting, “Collective Wisdom – The Future of Patient-Centered Care and Research,” is perfectly aligned with the goals of the Moonshot, Biden told the rapt audience.

    Read More
  8. Precision Medicine and Immunotherapy @ ASCO16

    The American Society of Clinical Oncology (#ASCO16) annual meeting featured several significant oral scientific presentations on the blood cancers over the weekend here in Chicago. CPX-351: A session on hematological malignancies Saturday afternoon included a discussion of final data from the Phase 3 clinical trial of Celator’s drug CPX-351 (Vyxeos ®). LLS invested substantially in this study through our Therapy Acceleration Program (TAP). The study was in a small subset of elderly pati...

    Read More
  9. Putting Patients at the Center of Care at #ASCO16

    The American Society of Clinical Oncology (#ASCO16) annual meeting kicked off today as more than 30,000 researchers from around the world converged in Chicago to share their latest clinical findings on treatments and diagnostics for all cancers, and to exchange ideas about how to improve outcomes for cancer patients. Putting patients at the center of cancer care and research is this year’s theme at ASCO, something we at The Leukemia & Lymphoma Society (LLS) try to do every day. Sprin...

    Read More
  10. Staying One Step Ahead of Myeloma – and Counting on New Research

    Myeloma is a beast. It is a complicated cancer with no cure and, with so many different types, no two patients are the same. Drugs can put it into remission, but it almost always comes back. And when it does, it’s a little more aggressive and needs to be attacked in a different way. This is knowledge I’ve been living with for four years now and I’m doing everything I can to stay one step ahead of my disease. Believing there was a cure down the line, I opted for a clinical tri...

    Read More